CAS: 387867-13-2 - 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Formel:C31H42N6O4
InChl:InChI=1/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)
InChI Key:InChIKey=UXXQOJXBIDBUAC-UHFFFAOYSA-N
SMILES:O=C(NC1=CC=C(OC(C)C)C=C1)N2CCN(C=3N=CN=C4C=C(OCCCN5CCCCC5)C(OC)=CC43)CC2
- Synonyme:
- (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide
- 1-Piperazinecarboxamide, 4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-
- 4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide
- 4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide
- Ct 53518
- Mln 0518
- Mln 518
- Tandutinib
- Tandutinib(TINIBS)
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Tandutinib REF: IN-DA007842CAS: 387867-13-2 | 98% | 60,00 €~145,00 € | Do 05 Dez 24 | |
Tandutinib REF: TM-T1667CAS: 387867-13-2 | 99.45% - ≥98% | 50,00 €~104,00 € | Do 12 Dez 24 | |
Tandutinib REF: 7W-GP3628CAS: 387867-13-2 | - - - | 143,00 €~206,00 € | Do 12 Dez 24 | |
Tandutinib REF: TR-T006550CAS: 387867-13-2 | - - - | 92,00 €~194,00 € | Di 17 Dez 24 | |
Tandutinib REF: 3D-FT28001CAS: 387867-13-2 | Min. 95% | 136,00 €~1.286,00 € | Mo 16 Dez 24 |
Ref: IN-DA007842
25mg | 60,00 € | ||
100mg | 102,00 € |
Tandutinib
Ref: TM-T1667
25mg | 50,00 € | ||
50mg | 63,00 € | ||
100mg | 84,00 € | ||
200mg | 104,00 € | ||
1mL*10mM (DMSO) | 58,00 € |
Ref: 7W-GP3628
1mg | 143,00 € | ||
5mg | 182,00 € | ||
10mg | 206,00 € |
Tandutinib
Kontrolliertes ProduktRef: TR-T006550
25mg | 92,00 € | ||
50mg | 126,00 € | ||
100mg | 194,00 € |
Tandutinib
Ref: 3D-FT28001
1g | 363,00 € | ||
5g | 1.286,00 € | ||
50mg | 136,00 € | ||
250mg | 179,00 € |